Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$592M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$432M |
| 3 |
CRH
CRH
|
+$395M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$231M |
| 5 |
Intel
INTC
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$558M |
| 2 |
Apple
AAPL
|
+$477M |
| 3 |
NVIDIA
NVDA
|
+$462M |
| 4 |
Microsoft
MSFT
|
+$444M |
| 5 |
Eli Lilly
LLY
|
+$299M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.42% |
| 2 | Healthcare | 12.89% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Richardson Electronics
RELL
$299M
| $1.29M | ﹤0.01% |
117,740
-9,903
| -8% | -$128K |
|
3027
Atlas Energy Solutions
AESI
$1.55B
| $1.28M | ﹤0.01% |
57,602
+9,833
| +21% | +$206K |
|
3028
Apogee Therapeutics
APGE
$10.2B
| $1.27M | ﹤0.01% |
+59,660
| New | +$1.31M |
|
3029
Tarsus Pharmaceuticals
TARS
$3.05B
| $1.27M | ﹤0.01% |
71,452
-179
| -0.2% | -$3.17K |
|
3030
Caribou Biosciences
CRBU
$158M
| $1.26M | ﹤0.01% |
264,243
+60,242
| +30% | +$374K |
|
3031
Arcutis Biotherapeutics
ARQT
$3.27B
| $1.26M | ﹤0.01% |
237,779
+27,170
| +13% | +$231K |
|
3032
Nano X Imaging
NNOX
$74.2M
| $1.26M | ﹤0.01% |
192,146
+12,742
| +7% | +$131K |
|
3033
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$927M
| $1.26M | ﹤0.01% |
133,044
+1,831
| +1% | +$18.4K |
|
3034
Microvision
MVIS
$52.6M
| $1.26M | ﹤0.01% |
38,267
+109
| +0.3% | +$4.99K |
|
3035
Boston Omaha
BOC
$419M
| $1.25M | ﹤0.01% |
76,439
+1,802
| +2% | +$32.3K |
|
3036
IQ MacKay Municipal Insured ETF
MMIN
$477M
| $1.25M | ﹤0.01% |
54,803
+3,317
| +6% | +$78.8K |
|
|
BLUE
3037
DELISTED
bluebird bio
BLUE
| $1.25M | ﹤0.01% |
20,573
+302
| +1% | +$21.2K |
|
3038
Methanex
MEOH
$4.35B
| $1.25M | ﹤0.01% |
27,730
-806
| -3% | -$34.5K |
|
3039
eHealth
EHTH
$39.4M
| $1.25M | ﹤0.01% |
168,660
+7,843
| +5% | +$61.6K |
|
3040
AnaptysBio
ANAB
$1.72B
| $1.25M | ﹤0.01% |
69,405
+24
| +0% | +$458 |
|
|
SLGC
3041
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.24M | ﹤0.01% |
518,638
-1,948
| -0.4% | -$4.31K |
|
3042
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.9B
| $1.23M | ﹤0.01% |
8,478
+6,550
| +340% | +$974K |
|
3043
iHeartMedia
IHRT
$460M
| $1.23M | ﹤0.01% |
389,719
-7,423
| -2% | -$28K |
|
|
MACK
3044
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.23M | ﹤0.01% |
99,703
-614
| -0.6% | -$7.43K |
|
3045
iShare MSCI Eurozone ETF
EZU
$9.96B
| $1.22M | ﹤0.01% |
28,907
+1,769
| +7% | +$79.3K |
|
3046
iShares ESG Advanced MSCI USA ETF
USXF
$1.52B
| $1.22M | ﹤0.01% |
35,192
-2,666
| -7% | -$96.4K |
|
|
BFK
3047
DELISTED
BlackRock Municipal Income Trust
BFK
| $1.22M | ﹤0.01% |
137,431
-31
| -0% | -$301 |
|
3048
Paysafe
PSFE
$341M
| $1.21M | ﹤0.01% |
100,914
+3,337
| +3% | +$40.6K |
|
3049
Eos Energy Enterprises
EOSE
$1.46B
| $1.21M | ﹤0.01% |
561,530
-5,848
| -1% | -$17.5K |
|
|
EU
3050
enCore Energy
EU
$235M
| $1.21M | ﹤0.01% |
370,296
+10,598
| +3% | +$27.4K |
|
Similar funds
Bank of New York Mellon's Q3 2023 Portfolio in Review
As of Q3 2023, Bank of New York Mellon held 4,503 positions worth $455B, down 4.5% from $476B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q3 2023 filing shows 126 new, 1,681 increased, 2,220 reduced and 160 closed positions. Its largest new stake was Invesco S&P 500 Quality ETF: 1,449,432 shares worth $72.5M. The largest sale was ExxonMobil, an estimated $558M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2023 buy was Invesco S&P 500 Quality ETF: 1,449,432 shares worth $72.5M.
- Bank of New York Mellon added most to Kenvue in Q3 2023, an estimated $592M increase.
- Bank of New York Mellon's biggest Q3 2023 reduction was ExxonMobil, cutting an estimated $558M.
- Bank of New York Mellon fully exited Life Storage, Inc. in Q3 2023, selling an estimated $131M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $455B portfolio in Q3 2023.
- Bank of New York Mellon opened 126 new positions and closed 160 in Q3 2023.
- Bank of New York Mellon's portfolio value fell 4.5% quarter-over-quarter to $455B.
Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.